Our findings identified EZH2-miR-29b/miR-30d-LOXL4 signaling pathway was involved in breast tumorigenesis, and suggested that the epigenetic modulation represents a potential therapeutic target for breast cancer by controlling macrophage activation.
No takes yet. Share an insight, caveat, or question.
Yin et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: